Pharmaceutical Sector Archives - IMAA – Institute for Mergers, Acquisitions, and Alliances

Deal Tectonics: At The Fault Line Of Growth Goals And Competitive Pressures

November 29, 2021December 9, 2015 by Christopher Kummer

by Ernst & Young
As the specialty pharmaceutical sector sees its ability to pursue large acquisitions evaporate, long-promised organic growth from big pharma new drug launches has finally arrived. But a renewed focus on value-based pricing, staunch competition across key therapeutic battlefields and consolidating payer clout may weaken the industry’s ability to reach revenue targets for both new and legacy therapeutics. […] Read more

Approach To The Issues Of Leadership In The Processes Of Companies’ Acquisitions

June 24, 2022July 19, 2015 by Christopher Kummer

Table 2 Approach to the issues of leadership in the process of acquisition in the examined pharmaceutical companies

by Elsevier Ltd.
This paper presents the results of the research concerning five transactions in the pharmaceutical sector. The research aim was to diagnose an approach to the issues of leadership, which in the literature is often treated as a key success factor in the processes of acquisitions. The research showed that in the analyzed pharmaceutical companies which participated in the research little attention was paid to the issues of leadership. […] Read more

Dealing With Uncertainty: Strategies For Overcoming Compliance Risk And Regulatory Challenges In Cross-Border M&A

August 21, 2023March 5, 2015 by Christopher Kummer

by Baker & McKenzie
When you look at the numbers, there’s no question why global pharmaceutical companies have set their sights on emerging markets for future growth. From 2012 to 2017, global pharmaceutical sales are expected to rise 13% in the “pharmerging markets,” compared to 2% for the top mature markets, according to the IMS Institute for Healthcare Informatics. […] Read more

Are you sure youwant to log out?

Are you sure you
want to log out?